Skip to main content

Table 2 Effects of the treatment on the assessed variables for all participants

From: Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis

 

Δ6 m

P

BMI (kg/m 2 )

0.45 ± 0.07

0.466

DAS

-2.37 ± 0.4

0.000

HAQ

-0.4 ± 0.01

0.001

ESR (mm/h)

-18.55 ± 12.8

0.002

CRP (μg/L)

-16.1 ± 9.4

0.016

HOMA

-0.2 ± 0.1

0.088

QUICKI

0.03 ± 0.022

0.092

  1. Δ6 m, mean difference between baseline and six-month measurement; BMI, body mass index; CRP, C-reactive protein; DAS, Disease Activity Score 28; ESR, erythrocyte sedimentation rate; HAQ, Health Assessment Questionnaire; HOMA, Homeostasis Model Assessment Of Insulin Resistance; QUICKI, Quantitative Insulin Sensitivity Check Index.
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us